Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $5.3300 (-15.66%) ($4.6200 - $6.3700) on Fri. Apr. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 18.63% (three month average) | RSI | 52 | Latest Price | $5.3300(-15.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -15% a day on average for past five trading days. | Weekly Trend | SONN declines -28.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IWN(75%) EWP(92%) IWD(70%) IDRV(94%) INDA(79%) | Factors Impacting SONN price | SONN will decline at least -9.315% in a week (0% probabilities). TIP(-3%) PCY(13%) SIL(25%) VIXM(-49%) UUP(-45%) | | | | | Relative Volatility | | | | Market Trend Strength | -9.315% (StdDev 18.63%) | Hourly BBV | 0 () | Intraday Trend | -14.3% | | | |
|
1 - 5 Day Possible Target | $-43.49(-915.95%) | Resistance Level | $12.46 | 5 Day Moving Average | $8.45(-36.92%) | 10 Day Moving Average | $10.88(-51.01%) | 20 Day Moving Average | $12.46(-57.22%) | To recent high | -79.9% | To recent low | 0% | Market Cap | $49m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |